tiprankstipranks
Trending News
More News >
Arrayit Corporation (ARYC)
OTHER OTC:ARYC
US Market

Arrayit (ARYC) Price & Analysis

Compare
19 Followers

ARYC Stock Chart & Stats

$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)

ARYC FAQ

What was Arrayit Corporation’s price range in the past 12 months?
Arrayit Corporation lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
    What is Arrayit Corporation’s market cap?
    Arrayit Corporation’s market cap is $793.00.
      When is Arrayit Corporation’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Arrayit Corporation’s earnings last quarter?
      Currently, no data Available
      Is Arrayit Corporation overvalued?
      According to Wall Street analysts Arrayit Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Arrayit Corporation pay dividends?
        Arrayit Corporation does not currently pay dividends.
        What is Arrayit Corporation’s EPS estimate?
        Arrayit Corporation’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Arrayit Corporation have?
        Arrayit Corporation has 793,475,000 shares outstanding.
          What happened to Arrayit Corporation’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Arrayit Corporation?
          Currently, no hedge funds are holding shares in ARYC
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Arrayit Corporation

            Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others. The company also provides automated microarray manufacturing instruments, including NanoPrint, SpotBot Titan, SpotBot Extreme, SpotBo Protein, and Personal microarrayers, as well as SpotLight CCD fluorescence scanners, SpotWare colorimetric scanners, InnoScan laser scanners, TrayMix hybridization stations, ArrayMix hybridization stations, centrifuges, air jets, vacuum products, and laboratory tools and bioinformatics computers. In addition, it manufactures consumables, such as glass substrates and slides, reagents, solutions, kits, and clean room supplies; and provides variation identification platform technology that allows diagnostic tests to be performed by depositing approximately 100,000 patient samples onto a single microarray. Further, the company is involved in the import, export, manufacture, and distribution of wholesale industrial chemicals. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies. The company is headquartered in Sunnyvale, California.
            Similar Stocks
            Company
            Price & Change
            Follow
            Scinai Immunotherapeutics
            PainReform
            MSP Recovery
            NewcelX
            Conduit Pharmaceuticals

            Ownership Overview

            <0.01%100.00%
            Insiders
            Mutual Funds
            <0.01% Other Institutional Investors
            100.00% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks